Myeloma Rounds Seattle
March 20, 2025
Format
Live, In-Person Event
*Pre-registration required
Live interactive continuing medical education activity for healthcare professionals in Renton, Seattle, Tacoma, and surrounding areas to discuss multiple myeloma updates and challenges in treatment.
Target Audience
This activity is intended for hematologists-oncologists, medical oncologists, physician associates, nurse practitioners, nurses and pharmacists involved in the care of patients with myeloma.
Agenda
6:30 PM – Dinner and Networking
7:00 PM – Overview of Program and Updates in Treatment
Andrew J. Cowan
7:10 PM – Overview of LLS Resources, including the Clinical Trial Support Center
Ashley Giacobbi
7:20 PM – Clinical Trials for the Treatment of Smoldering Multiple Myeloma
Rahul Banerjee and TBA
7:50 PM – Extramedullary Disease in Multiple Myeloma
Henry Li and Swathi Namburi
8:20 PM – Optimizing Unique Toxicities Related to Targeted Therapy
Grace Baek and Miryoung Kim
8:50 PM – Discussion and Wrap-up
All Faculty
9:00 PM – Conclusion
Andrew J. Cowan
Educational Objectives
At the conclusion of this activity, participants will be better able to:
- Describe the latest developments in myeloma, including current and emerging treatments
- Engage patients and caregivers in discussions on clinical trials, newly approved therapies and emerging therapies for myeloma, including combination therapies, CAR T-cell therapy and bi-specific antibodies
- Identify disparities and challenges in diagnosis and treatment of myeloma
- Apply evidence-based treatment strategies for optimal patient care
- Access patient support resources
Advisory Group
Andrew J. Cowan, MD (Chair)
Fred Hutchinson Cancer Center
University of Washington School of Medicine
Seattle, WA
Ivan Huang, PharmD, BCOP
Fred Hutchinson Cancer Center
University of Washington School of Medicine
Seattle, WA
Mohammed Kanaan, MD
Northwest Medical Specialties
Tacoma, WA
Swathi Namburi, MD
Swedish Cancer Institute
Seattle, WA
Faculty
Andrew J. Cowan, MD (Chair)
Fred Hutchinson Cancer Center
University of Washington School of Medicine
Seattle, WA
Grace Baek, PharmD, BCOP
Fred Hutchinson Cancer Center
Seattle, WA
Rahul Banerjee, MD, FACP
Fred Hutchinson Cancer Center
Seattle, WA
Ashley Giacobbi, DNP, RN, ACNS-BS, AOCNS, OCN
The Leukemia & Lymphoma Society
Rye Brook, NY
Miryoung Kim, PharmD, BCOP
Fred Hutchinson Cancer Center
Seattle, WA
Henry Li, MD
Optum Washington
Seattle, WA
Swathi Namburi, MD
Swedish Cancer Institute
Seattle, WA
Additional Faculty TBA
Continuing Education Information
Accreditation, Credit and Support
In support of improving patient care, this activity has been planned and implemented by Medical Learning Institute Inc and The Leukemia & Lymphoma Society. Medical Learning Institute Inc is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Physician Continuing Medical Education
Medical Learning Institute Inc (MLI) designates this live activity for a maximum of 2.0 AMA PRA Category 1 Credits™.
Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Physician Associate
Medical Learning Institute Inc has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 2.0 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation
Pharmacy
Medical Learning Institute Inc designates this application-based continuing education activity for 2.0 contact hours (0.2 CEUs) of the Accreditation Council for Pharmacy Education.
Universal Activity Number: JA0007322-9999-25-010-L01-P
For Pharmacists, Medical Learning Institute will accept your completed evaluation form for up to 30 days post-activity and will report your participation to the NABP only if you provide your NABP e-Profile number and DOB (MM/DD). Within 6 weeks, you can view your participation record at the NABP website: https://nabp.pharmacy/
Nursing Continuing Professional Development Contact Hours
Approval for nurses has been obtained by the National Office of The Leukemia & Lymphoma Society under Provider Number CEP 5832 to award 2.0 continuing education contact hour through the California Board of Registered Nursing.
Interprofessional Continuing Education Credit
This activity was planned by and for the healthcare team, and learners will receive 2.0 Interprofessional Continuing Education (IPCE) credits for learning and change.
Method of Participation
There are no fees for participating in or receiving credits for this CE activity. For information on applicability and acceptance of continuing education credit for this activity, please consult your professional licensing board.
In order to receive credit, learners must participate in the entire CE activity, complete the activity evaluation form and return it to staff at the end of the program. A certificate of completion will be emailed within 30 days of receipt. If you have questions regarding the receipt of your certificate, please contact us via email at ndane@mlieducation.org.
Providers
This activity is provided by The Leukemia & Lymphoma Society and Medical Learning Institute Inc, in collaboration with the Association of Cancer Care Centers™ (ACCC).
Supporters
Supported by an educational grant from Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC.
For questions, concerns, or assistance for people with disabilities or grievances, please contact us at: profeducation@LLS.org.